 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | XW10508 / XWPharma
Enrollment open, Trial initiation date: An Open Label Safety and Efficacy Study of XW10508 Modified Release (MR) in Patients with Major Depressive Disorder (EUDRACT) - Apr 19, 2024
P2, N=24, Recruiting, Sponsor: XW Laboratories (Australia) Pty Ltd
Not yet recruiting --> Recruiting
- | XW10508 / XWPharma
New P2 trial: An Open Label Safety and Efficacy Study of XW10508 Modified Release (MR) in Patients with Major Depressive Disorder (EUDRACT) - Nov 2, 2023
P2, N=24, Not yet recruiting, Sponsor: XW Laboratories (Australia) Pty Ltd
- ||| XW10508 / XWPharma
Trial completion, Trial completion date, Trial primary completion date: Safety, Tolerability and Pharmacokinetics of XW10508 Immediate and Modified Release Formulations in Healthy Adults (clinicaltrials.gov) - Nov 4, 2022
P1, N=84, Completed, Sponsor: XWPharma
Not yet recruiting --> Recruiting Recruiting --> Completed | Trial completion date: Dec 2021 --> Jun 2022 | Trial primary completion date: Dec 2021 --> Jun 2022
- ||| XW10508 / XWPharma
New P1 trial: Safety, Tolerability and Pharmacokinetics of XW10508 Immediate and Modified Release Formulations in Healthy Adults (clinicaltrials.gov) - Jul 18, 2021
P1, N=84, Recruiting, Sponsor: XWPharma